Health News Archive - February 01, 2010
BRIDGEWATER, N.J., Feb. 1 /PRNewswire/ -- Cordis Corporation, a Johnson & Johnson company, announced today that it has reached an agreement with Boston Scientific resolving two Delaware litigations related to Cordis's Palmaz and Gray patents and Boston Scientific's Jang patents.
WASHINGTON, Feb. 1 /PRNewswire-FirstCall/ -- Danaher Corporation (NYSE: DHR) announced today that it has completed the previously announced acquisition of AB SCIEX and Molecular Devices.
REDWOOD CITY, Calif., Feb.
NEW YORK, Feb. 1 /PRNewswire/ -- A new functional supplement using CognizinÂ® Citicoline from Kyowa Hakko USA in the patent-pending formulation has been introduced by Nawgan Products, LLC of Chesterfield, MO.
PALO ALTO, Calif., Feb. 1 /PRNewswire/ -- TOPICA Pharmaceuticals, a privately-held biotechnology company, today announced that the U.S.
TORONTO, Feb. 1 /PRNewswire-FirstCall/ - MDS Inc.
TORONTO, Feb. 1 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life-sciences markets, today announced the appointment of William D. Anderson as Chair of the Company's Board of Directors. Mr.
LA JOLLA, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) announced today that it has retained WBB Securities LLC to help the company explore strategic alternatives to enhance shareholder value.
NORTHBROOK, Ill., Feb. 1 /PRNewswire/ -- There are no instant replays when it comes to hosting a party or playing it safe on Super Bowl Sunday.
MEDFORD, Mass., Feb. 1 /PRNewswire/ -- Preservation of amniotic fluid stem cells is an innovative technology that recently became available to expecting mothers in the United States with Biocell Center having launched its pioneering service here following its success in Europe.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.